Ted Gooley received a Bachelor’s degree in Mathematics from Washington State University in Pullman (Go Cougs!). He obtained his Ph.D. from the Program in Applied Mathematics at the University of Arizona in Tucson. After a one-year post-doctoral position at the University of Rochester (New York), he joined the Clinical Research Division at Fred Hutch and has been here since 1992, where he has been involved in numerous studies (both clinical trials and observational studies) in the area of hematopoietic cell transplant. Outside the workplace, Ted enjoys time with his wife and their daughter. He also has a passion for sports and is known to be willing to discuss such matters with anyone who is interested, particularly when it comes to March Madness.
Vicky Wu received her Ph.D. in Biostatistics at the University of Pennsylvania in 2013. Prior to joining Fred Hutch, Vicky worked as a consultant for two and a half years. She joined the Clinical Research Division at Fred Hutch in June, 2016. Vicky has broad experience and expertise in statistical genetics, biomarker analysis and clinical trials. She has worked as the primary statistician/co-investigator in multiple aspects of drug development and clinical trials, including phase II and phase III studies of head and neck cancer, prostate cancer, glioblastoma multiforme, and the observational study of late stage lung cancer and breast cancer, etc. Her major research focus is using complex genetic/biomarker information to optimize trial design and developing efficient statistical algorithms to identify patient subgroups with better/worse responses to a particular treatment. Vicky is also a science fiction fan and writer. Her favorite sport team is Man United, though her husband and son are Gunners.
Mary Redman earned her Ph.D. in Biostatistics at the University of Washington in 2004 and joined Fred Hutch in 2005. She has extensive experience in designing, monitoring, and analyzing cancer clinical trials. She is the lead statistician for the Lung Committee and the Lung-MAP trial in SWOG. She has worked at least 50-60 Phase I, II, and III clinical trials in lung, other solid tumor cancers, and sarcoma and lymphoma. Her area of focus is on clinical trial design incorporating potentially predictive biomarkers.
Kelsey Baker attended Saint Martin’s University and the University of Pittsburgh earning a B.A. in Mathematics and an M.S. in Biostatistics. She was born and raised in Spokane, but has a new found love for western Washington and Seattle living. When she is not providing statistical support for Phase II clinical trials at the Hutch, you can find her exploring the diverse opportunities found in the Pacific Northwest such as scaling Mt. Rainier and enjoying a cone at Molly Moons.
After spending time with the US Army as an Infantryman, Isaac Jenkins attained his B.A. in Mathematics and M.S. in Statistics at the University of Arizona. He later came to Fred Hutch to further expand his detail oriented approach to statistics. His research interests include R-programming, reproducible research and data visualization. But his most valued achievement comes in the form of beating Sonic the Hedgehog without dying (he even collected all the Chaos Emeralds).
Lynn Onstad has a B.A. in Mathematics from St. Olaf College and a Sc.M. in Biostatistics from the Johns Hopkins Bloomberg School of Public Health. She worked for 2 years at the GWU Biostatistics Center in Maryland before moving to Seattle in 1991, at which point she started working at Fred Hutch and has been here ever since. After working for many years in the Public Health Sciences division, she recently joined the Clinical Biostatistics group. Outside of work Lynn enjoys spending time with family and friends and taking advantage of all the great outdoor activities the northwest has to offer.